Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM

1.54 Up 0.03(1.99%) May 17, 4:00PM EDT|After Hours : 1.54 0.00 (0.00%) May 17, 7:31PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 29, 2012Apr 29, 2011Apr 29, 2010
Total Revenue 15,233   13,492   27,943  
Cost of Revenue10,153  7,296  8,716  
Gross Profit 5,080   6,196   19,227  
Operating Expenses
Research Development35,688  29,462  24,658  
Selling General and Administrative11,462  11,421  8,182  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (42,070) (34,687) (13,613)
Income from Continuing Operations
Total Other Income/Expenses Net41  1,052  116  
Earnings Before Interest And Taxes(42,029)(33,635)(13,497)
Interest Expense90  516  997  
Income Before Tax(42,119)(34,151)(14,494)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(42,119)(34,151)(14,494)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (42,119) (34,151) (14,494)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (42,119) (34,151) (14,494)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.